These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10509759)

  • 1. Inhibition of protein synthesis by didemnin B is not sufficient to induce apoptosis in human mammary carcinoma (MCF7) cells.
    Beidler DR; Ahuja D; Wicha MS; Toogood PL
    Biochem Pharmacol; 1999 Sep; 58(6):1067-74. PubMed ID: 10509759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of protein synthesis by didemnin B: how EF-1alpha mediates inhibition of translocation.
    Ahuja D; Vera MD; SirDeshpande BV; Morimoto H; Williams PG; Joullié MM; Toogood PL
    Biochemistry; 2000 Apr; 39(15):4339-46. PubMed ID: 10757982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unspecific activation of caspases during the induction of apoptosis by didemnin B in human cell lines.
    Johnson KL; Grubb DR; Lawen A
    J Cell Biochem; 1999 Feb; 72(2):269-78. PubMed ID: 10022509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A specific binding site in Nb2 node lymphoma cells mediates the effects of didemnin B, an immunosuppressive cyclic peptide.
    Shen GK; Zukoski CF; Montgomery DW
    Int J Immunopharmacol; 1992 Jan; 14(1):63-73. PubMed ID: 1582735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein tyrosine kinase inhibitors prevent didemnin B-induced apoptosis in HL-60 cells.
    Johnson KL; Vaillant F; Lawen A
    FEBS Lett; 1996 Mar; 383(1-2):1-5. PubMed ID: 8612773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid and selective apoptosis in human leukemic cells induced by Aplidine through a Fas/CD95- and mitochondrial-mediated mechanism.
    Gajate C; An F; Mollinedo F
    Clin Cancer Res; 2003 Apr; 9(4):1535-45. PubMed ID: 12684430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of T-lymphocyte proliferation by the cyclic polypeptide didemnin B: no inhibition of lymphokine stimulation.
    Legrue SJ; Sheu TL; Carson DD; Laidlaw JL; Sanduja SK
    Lymphokine Res; 1988; 7(1):21-9. PubMed ID: 3258949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of protein synthesis inhibition by didemnin B in vitro.
    SirDeshpande BV; Toogood PL
    Biochemistry; 1995 Jul; 34(28):9177-84. PubMed ID: 7619818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapamycin inhibits didemnin B-induced apoptosis in human HL-60 cells: evidence for the possible involvement of FK506-binding protein 25.
    Johnson KL; Lawen A
    Immunol Cell Biol; 1999 Jun; 77(3):242-8. PubMed ID: 10361256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Didemnin B: a new immunosuppressive cyclic peptide with potent activity in vitro and in vivo.
    Montgomery DW; Zukoski CF
    Transplantation; 1985 Jul; 40(1):49-56. PubMed ID: 2409649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic 1,4-anthracenedione analogs induce cytochrome c release, caspase-9, -3, and -8 activities, poly(ADP-ribose) polymerase-1 cleavage and internucleosomal DNA fragmentation in HL-60 cells by a mechanism which involves caspase-2 activation but not Fas signaling.
    Perchellet EM; Wang Y; Weber RL; Sperfslage BJ; Lou K; Crossland J; Hua DH; Perchellet JP
    Biochem Pharmacol; 2004 Feb; 67(3):523-37. PubMed ID: 15037204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Didemnin B induces cell death by apoptosis: the fastest induction of apoptosis ever described.
    Grubb DR; Wolvetang EJ; Lawen A
    Biochem Biophys Res Commun; 1995 Oct; 215(3):1130-6. PubMed ID: 7488040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Didemnin B induces apoptosis in proliferating but not resting peripheral blood mononuclear cells.
    Baker MA; Grubb DR; Lawen A
    Apoptosis; 2002 Oct; 7(5):407-12. PubMed ID: 12207173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression.
    Fulda S; Meyer E; Debatin KM
    Cancer Res; 2000 Jul; 60(14):3947-56. PubMed ID: 10919673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total synthesis of [(2S)-Hiv2]didemnin M.
    Liang B; Vera MD; Joullié MM
    J Org Chem; 2000 Jul; 65(15):4762-5. PubMed ID: 10959892
    [No Abstract]   [Full Text] [Related]  

  • 16. Sensitization to CD95 ligand-induced apoptosis in human glioma cells by hyperthermia involves enhanced cytochrome c release.
    Hermisson M; Wagenknecht B; Wolburg H; Glaser T; Dichgans J; Weller M
    Oncogene; 2000 May; 19(19):2338-45. PubMed ID: 10822385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The novel antimicrotubule agent cryptophycin 52 (LY355703) induces apoptosis via multiple pathways in human prostate cancer cells.
    Drew L; Fine RL; Do TN; Douglas GP; Petrylak DP
    Clin Cancer Res; 2002 Dec; 8(12):3922-32. PubMed ID: 12473608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiwavelength videomicrofluorometric study of cytotoxic properties of a marine peptide, didemnin B, using adriamycin as reference compound.
    Rocchi E; Vigo J; Viallet P; Bonnard I; Banaigs B; Salmon JM
    Anticancer Res; 1999; 19(4C):3559-68. PubMed ID: 10629653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of protein synthesis by didemnins: cell potency and SAR.
    Ahuja D; Geiger A; Ramanjulu JM; Vera MD; SirDeshpande B; Pfizenmayer A; Abazeed M; Krosky DJ; Beidler D; Joullié MM; Toogood PL
    J Med Chem; 2000 Nov; 43(22):4212-8. PubMed ID: 11063617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of didemnin photoaffinity analogues.
    Vera MD; Pfizenmayer AJ; Ding X; Ahuja D; Toogood PL; Joullié MM
    Bioorg Med Chem Lett; 2001 Jul; 11(14):1871-4. PubMed ID: 11459650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.